LY2033298, a positive allosteric modulator at muscarinic M4 receptors, enhances inhibition by oxotremorine of light-induced phase shifts in hamster circadian activity rhythms

Psychopharmacology

Volumn 224, Issue 2, 2012, Pages 231-240

  Gannon, Robert L ^a   Millan, Mark J ^b  

^a VALDOSTA STATE UNIVERSITY   (United States)

^b CNS Unit   (France)

Author keywords

Alzheimer's; Biological rhythms; Circadian; Depression; Muscarinic; Schizophrenia

Indexed keywords

3 AMINO 5 CHLORO N CYCLOPROPYL 6 METHOXY 4 METHYLTHIENO[2,3 B]PYRIDINE 2 CARBOXAMIDE; LY 2033298; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; OXOTREMORINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; DRUG SCREENING; HAMSTER; LIGHT; MALE; MONOTHERAPY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RUNNING;

ANIMALS; CIRCADIAN RHYTHM; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGHT; MALE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NICOTINIC ACIDS; OXOTREMORINE; RECEPTOR, MUSCARINIC M4; SCOPOLAMINE HYDROBROMIDE; THIOPHENES;

EID: 84868204827     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2743-8     Document Type: Article

References (57)

1. Antoniadis EA, Ko CH, Ralph MR, McDonald RJ (2000) Circadian rhythms, aging and memory. Behav Brain Res 114:221-233
2. Bina KG, Rusak B (1996) Muscarinic receptors mediate carbachol-induced phase shifts of circadian activity rhythms in Syrian hamsters. Brain Res 743:202-211 (Pubitemid 27028773)
3. Bina KG, Rusak B, Semba K (1993) Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rat. J Comp Neurol 335:295-307 (Pubitemid 23256194)
4. Bina KG, Rusak B, Wilkinson M (1998) Daily variation of muscarinic receptors in visual cortex but not suprachiasmatic nucleus of Syrian hamsters. Brain Res 797:143-153 (Pubitemid 28331499)
5. Birks J, Harvey RJ (2006) Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev, January 25; (1):CD001190
6. Brady AE, Jones CK, Bridges TM, Kennedy JP, Thompson AD, Heiman JU, Breininger ML, Gentry PR, Yin H, Jadhav SB, Shirey JK, Conn PJ, Lindsley CW (2008) Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats. J Pharmacol Exp Ther 327:941-953
7. Bridges TM, LeBois EP, Hopkins CR, Wood MR, Jones CK, Conn PJ, Lindsley CW (2010) The antipsychotic potential of muscarinic allosteric modulation. Drug News Perspect 23:229-240
8. Brischoux F, Mainville L, Jones BE (2008) Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 510:607-630
9. Bromundt V, Koster M, Georgiev-Kill A, Opwis K, Wirz-Justice A, Stoppe G, Cajochen C (2011) Sleep-wake cycles and cognitive functioning in schizophrenia. Br J Psychiatry 198:269-276
10. Buchanan GF, Gillette MU (2005) New light on an old paradox: sitedependent effects of carbachol on circadian rhythms. Exp Neurol 193:489-496 (Pubitemid 40616196)
11. Cain SW, Verwey M, Szybowska M, Ralph MR, Yeomans JS (2007) Carbachol injections into the intergeniculate leaflet induce non-photic phase shifts. Brain Res 1177:59-65 (Pubitemid 47561886)
12. Chan WY, McKinzie DL, Bose S, Mitchell SN, Witkin JM, Thompson RC, Christopoulos A, Lazareno S, Birdsall NJM, Bymaster FP, Felder CC (2008) Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. Proc Natl Acad Sci USA 105:10978-10983
13. Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30:148-155
14. Digby GJ, Shirley JK, Conn PJ (2010) Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Mol Biosyst 6:1345-1354
15. Duncan WC (1996) Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 71:253-312
16. Fisher SK, Figueiredo JC, Bartus RT (1984) Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine. J Neuroschem 43:1171-1179 (Pubitemid 14011275)
17. Francis PT, Ramírez MJ, Lai MK (2010) Neurochemical basis for symptomatic treatment of Alzheimer's disease. Neuropharmacology 59:221-229
18. 2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram. Eur Neuropsychopharmacol 19:887-897
19. Germain A, Kupfer DJ (2008) Circadian rhythm disturbances in depression. Hum Psychopharmacol Clin Exp 23:571-585
20. Gillette MA, Buchanan GF, Artinian L, Hamilton SE, Mathanson NM, Liu C (2001) Role of the M1 receptor in regulating circadian rhythms. Life Sci 68:2467-2472 (Pubitemid 32455683)
21. Gray JA, Roth BL (2007) The pipeline and future of drug development in schizophrenia. Mol Psychiatry 12:904-922 (Pubitemid 47482704)
22. Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R et al (2001) Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 58:353-360 (Pubitemid 32303191)
23. Hastings M, O'Neill JS, Maywood ES (2007) Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol 195:187-198 (Pubitemid 350143100)
24. Hut RA, van der Zee EA (2011) The cholinergic system, circadian rhythmicity, and time memory. Behav Brain Res 221:466-480
25. Janik D, Mrosovsky N (1994) Intergeniculate leaflet lesions and behaviorally-induced shifts of circadian rhythms. Brain Res 651:174-182 (Pubitemid 24222865)
26. Keefe DL, Earnest DJ, Nelson D, Takahashi JS, Turek FW (1987) A cholinergic antagonist, mecamylamine, blocks the phase-shifting effects of light on the circadian rhythm of locomotor activity in the golden hamster. Brain Res 403:308-312 (Pubitemid 17019712)
27. Ketchum JS, Sidell FR, Crowell EB, Aghajanian GK, Hayes AH (1973) Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man. Psychopharmacologia 28:121-145
28. Kohsaka A, Bass J (2006) A sense of time: how molecular clocks organize metabolism. Trends Endocrin Metab 18:4-11 (Pubitemid 44960013)
29. Kriegsfeld LJ, Silver R (2006) The regulation of neuroendocrine function: timing is everything. Hormones Behav 49:557-574
30. Langmead CJ, Watson J, Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117:232-243
31. Leach K, Loiacono RE, Felder CC, McKinzie DL, Mogg A, Shaw DB, Sexton PM, Christopoulos A (2010) Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties. Neuropsychopharmacology 35:855-869
32. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31-41
33. Liu C, Gillette MU (1996) Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J Neurosci 16:744-751 (Pubitemid 26028833)
34. Martin JL, Jeste DV, Ancoli-Israel S (2005) Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. J Psychiatr Res 39:251-259 (Pubitemid 40267709)
35. Meijer JH, van der Zee E, Dietz M (1988) The effects of intraventricular carbachol injections on the free-running activity rhythm of the hamster. J Biol Rhythms 3:333-348
36. Monleon S, Urquiza A, Vinader-Caerols C, Parra A (2009) Effects of oxotremorine and physostigmine on the inhibitory avoidance impairments produced by amitriptyline in male and female mice. Behav Brain Res 205:367-371
37. Morin LP, Allen CN (2006) The circadian visual system. Brain Res Rev 51:1-60
38. Pace-Schott EF, Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3:591-605 (Pubitemid 135706668)
39. Ralph MR, Foster RG, Davis FC, Menaker M (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247:975-978
40. Rezvani AH, Cauley M, Sexton H, Xiao Y, Brown ML, Paige MA, McDowell BE, Kellar KJ, Levin ED (2011) Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. Psychopharmacology (Berl) 215:621-630
41. Scarr E, Dean B (2008) Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia? J Neurochem 107:1188-1195
42. Scibelli AC, Phillips TJ (2009) Combined scopolamine and ethanol treatment results in a locomotor stimulant response suggestive of synergism that is not blocked by dopamine receptor antagonists. Alcohol Clin Exp Res 33:435-447
43. Shirey JK, Xiang Z, Orton D, Brady AE, Johnson KA, Williams R, Ayala JE, Rodriguez AL, Wess J, Weaver D, Niswender CM, Conn PJ (2008) An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. Nat Chem Biol 4:42-50 (Pubitemid 350273654)
44. Srikumar BN, Raju TR, Shankaranarayana Rao BS (2006) The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats. Neuroscience 143:679-688 (Pubitemid 44781287)
45. Steriade M (2004) Acetylcholine systems and rhythmic activities during the waking-sleep cycle. Prog Brain Res 145:179-196 (Pubitemid 37442944)
46. Suratman S, Leach K, Sexton P, Felder C, Loiacono R, Christopoulos A (2011) Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor. Br J Pharmacol 162:1659-1670
47. Takahashi JS, Hong H-K, Ko CH, McDearmon EL (2008) The genetics of mammalian circadian order and disorder: implication for physiology and disease. Nat Rev Genet 9:764-775
48. Turner J, Hughes LF, Toth LA (2010) Sleep, activity, temperature and arousal responses of mice deficient for muscarinic receptor M2 or M4. Life Sci 86:158-169
49. Ukai M, Kobayashi T, Kameyama T (1994) Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine. Gen Pharmacol 25:433-438 (Pubitemid 24173056)
50. Valant C, Felder CC, Sexton PM, Christopoulos A (2012) Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects. Mol Pharmacol 8:41-52
51. Van der Zee EA, Streefland C, Strosberg AD, Schroder H, Luiten PGM (1991) Colocalization of muscarinic and nicotinic receptors in cholinoceptive neurons of the suprachiasmatic region in young and aged rats. Brain Res 542:348-352
52. Van der Zee EA, Biemans BA, Gerkema MP, Daan S (2004) Habituation to a test apparatus during associative learning is sufficient to enhance muscarinic acetylcholine receptor-immunoreactivity in rat suprachiasmatic nucleus. J Neurosci Res 78:508-519 (Pubitemid 39536495)
53. Waters F, Sinclair C, Rock D, Jablensky A, Foster RG, Wulff K (2011) Daily variations in sleep-wake patterns and severity of psychopathology: a pilot study in community-dwelling individuals with chronic schizophrenia. Psychiatry Res 187:304-306
54. Wee BEF, Anderson KD, Kouchis NS, Turek FW (1992) Administration of carbachol into the lateral ventricle and suprachiasmatic nucleus (SCN) produces dose-dependent phase shifts in the circadian rhythm of locomotor activity. Neurosci Lett 137:211-215
55. Woolley ML, Carter HJ, Gartlon JE, Watson JM, Dawson LA (2009) Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice. Eur J Pharmacol 603:147-149
56. Yang JJ, Wang YT, Cheng PC, Kuo YJ, Huang RC (2010) Cholinergic modulation of neuronal excitability in the rat suprachiasmatic nucleus. J Neurophysiol 103:1397-1409
57. Zatz M, Herkenham MA (1981) Intraventricular carbachol mimics the phase-shifting effect of light on the circadian rhythm of wheel-running activity. Brain Res 212:234-238 (Pubitemid 11100811)